Cytori Therapeutics (CYTX) Announces Receipt of FDA Orphan Drug Designation for ECCS-50 in Scleroderma
Go back to Cytori Therapeutics (CYTX) Announces Receipt of FDA Orphan Drug Designation for ECCS-50 in Scleroderma| Cytori Therapeutics, Inc. (NASDAQ: CYTX) | Delayed: 0.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.21 | 52 Week High | $3.30 | |||
| Open | $10.42 | 52 Week Low | $0.13 | |||
| Day High | $0.21 | P/E | N/A | |||
| Day Low | $0.21 | EPS | $-0.30 | |||
| Volume | 0 | |||||
